The UK is witnessing a growing surge in interest surrounding entheogenic substances. Beyond the familiar use of psilocybin and LSD, scientists and enthusiasts are increasingly focused on less-charted areas, particularly copyright and the budding cannabinoid, CBG. This burgeoning movement encompasses clinical trials into emotional healing, emerging